The Society for Immunotherapy of Cancer’s annual meeting focuses on earlier stage agents in the rapidly growing field of immuno-oncology. Many agents in preclinical development are first disclosed at this event, and early tumor-specific IO trials are also presented. The ONCrg team of experts is optimally positioned to interpret new candidates in the context of their mechanism of action, and to provide guidance as candidates advance into specific tumor types.
Drawing on expertise honed year-round by our dedicated disease area specialists, ONCrg prepares detailed agendas identifying high-impact presentations. During and immediately after the conference, our team of experts sifts through the presentations, paying close attention to details while also placing them into the context of the clinical landscape at large. ONCrg’s unique conference reports provide clients with clear, digestible top-line trends backed by granular developments. Ask our Conference Lead Analyst about ONCrg Conference coverage.